Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Detection of clinical relapses in multiple sclerosis cohorts: construction and validation of a model based on administrative data.
A Long-Term Follow-Up Study Using IPMSSG Criteria in Children With CNS Demyelination.
Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosis.
Stratified mixture modeling for segmentation of white-matter lesions in brain MR images.
High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: A case report.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Walking function in clinical monitoring of multiple sclerosis by telemedicine.
The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis.
Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction.
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children.
Transplanted microvascular endothelial cells promote oligodendrocyte precursor cell survival in ischemic demyelinating lesions.
Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis.
Inflammatory Cytokines and Physical Activity in Multiple Sclerosis.
The many faces of impaired bladder emptying.
Recent advances and future challenges in the genetics of multiple sclerosis.
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis.
Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis.
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention.
Antigen-specific tolerization approaches in multiple sclerosis.
[Demyelinating process in systematic rheumatoid diseases (review)].
Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis.
The effect of triiodothyronine on maturation and differentiation of oligodendrocyte progenitor cells during remyelination following induced demyelination in male albino rat.
Pages
« first
‹ previous
…
575
576
577
578
579
580
581
582
583
…
next ›
last »